End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel...

Biology of Blood and Marrow Transplantation 2019 / 03 Vol. 25; Iss. 3

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma

Jacobson, Caron A., Locke, Frederick L., Miklos, David B., Herrera, Alex F., Westin, Jason R., Lee, Jennifer, Rossi, John M., Sun, Jennifer, Zheng, Lianqing, Avanzi, Mauro P., Roberts, Zachary J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2018.12.314
Date:
March, 2019
File:
PDF, 517 KB
english, 2019
Conversion to is in progress
Conversion to is failed